Remission of a refractory, anaplastic large-cell lymphoma after treatment with daclizumab [6]

New England Journal of Medicine

Volumn 351, Issue 14, 2004, Pages 1466-1467

  Lindén, Ola ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DACLIZUMAB; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HYBRID PROTEIN; IFOSFAMIDE; INTERLEUKIN 2 RECEPTOR; METHOTREXATE; PREDNISONE; PROSTACYCLIN; PROTEIN ALK; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ACUTE ABDOMEN; ADULT; ANAPLASTIC CARCINOMA; APOPTOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CHROMOSOME TRANSLOCATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LARGE CELL LYMPHOMA; LETTER; LYMPH NODE BIOPSY; PRIORITY JOURNAL; T CELL LEUKEMIA; HISTIOCYTIC LYMPHOMA; REMISSION;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, LARGE-CELL; REMISSION INDUCTION;

EID: 4644305096     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200409303511424     Document Type: Letter

References (5)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Vol. 3 of World Health Organization classification of tumours. Lyon, France: IARC Press, 2001.
2. Delsol G, Al Saati T, Gatter KC, et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: diagnostic value in so-called malignant histiocytosis. Am J Pathol 1988;130:59-70.
3. Waldmann TA. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma. Important Adv Oncol 1994:131-41.
4. Phillips KE, Herring B, Wilson LA, et al. IL-2Ralpha-directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Cancer Res 2000;60:6977-84.
5. Nicholl M, Lodge A, Brown I, Sugg SL. Restored immune response to an MHC-II-restricted antigen in tumor-bearing hosts after elimination of regulatory T cells. J Pediatr Surg 2004;39:941-6.